Showing results (511-520 of 5,582) with videos related to
Sort By:
Pageof 559
Nuclear Medicine Communications|June 14, 2001
Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 yearsM Chouker, K Tatsch, R Linke, et al.Nuclear Medicine Communications|August 16, 2001
Quality of dynamic radionuclide renal imaging: multicentre evaluation using a functional renal phantomJ O Heikkinen, J T Kuikka, A K Ahonen, et al.Nuclear Medicine Communications|August 16, 2001
Standard provocative manoeuvres in patients with and without left bundle branch block studied with myocardial SPECTJ Candell-Riera, G Oller-Martínez, J Rosselló, et al.Nuclear Medicine Communications|September 28, 2002
FDG-PET improves the management of patients with suspected recurrence of colorectal cancerM Simó, F Lomeña, J Setoain, et al.Nuclear Medicine Communications|September 28, 2002
99mTc-tetrofosmin scintigraphy in musculoskeletal tumours: the relationship between P-glycoprotein expression and tetrofosmin uptake in malignant lesionsZ Yapar, M Kibar, S Ozbarlas, et al.Nuclear Medicine Communications|September 28, 2002
Tissue distribution of octreotide binding receptors in normal mice and strains prone to autoimmunityA M C Ten Bokum, J G M Rosmalen, L J Hofland, et al.Nuclear Medicine Communications|September 22, 2001
The use of a whole body index with bone scintigraphy to monitor the response to therapy in Paget's diseaseK Griffith, D Pearson, C Parker, et al.Nuclear Medicine Communications|September 22, 2001
Pulmonary involvement in Behçet's disease: evaluation of 123 I-MIBG retentionM Unlü, C Akincioglu, K Yamaç, et al.Nuclear Medicine Communications|September 22, 2001
Localization of sentinel nodes in head and neck tumours by combined lymphoscintigraphy and bone scintigraphyG Margolin, M G Lind, S A Larsson, et al.Nuclear Medicine Communications|September 22, 2001
A novel [186/188Re]-labelled porphyrin for targeted radiotherapyS Banerjee, T Das, G Samuel, et al.Pageof 559